[1] 陆 林. 沈渔邨精神病学(第6版)[M]. 北京:人民卫生出版社,2018. [2] American Psychiatric Association.Diagnostic and statistical manual of mental disorders[M]. 5th ed. Arlington, VA, US:American Psychiatric Publishing, Inc.,2013. [3] Pitman R K, Rasmusson A M, Koenen K C, et al. Biological studies of post-traumatic stress disorder[J]. Nat Rev Neurosci, 2012, 13(11):769-787. [4] Bremner J D, Hoffman M, Afzal N, et al. The environment contributes more than genetics to smaller hippocampal volume in Posttraumatic Stress Disorder (PTSD)[J]. J Psychiatr Res, 2021, 137:579-588. [5] Almeida F B, Pinna G, Barros H M T. The role of HPA axis and allopregnanolone on the neurobiology of major depressive disorders and PTSD[J]. Int J Mol Sci, 2021, 22(11). [6] Traina G, Tuszynski J A. The neurotransmission basis of post-traumatic stress disorders by the fear conditioning paradigm[J]. Int J Mol Sci, 2023, 24(22). [7] Fleury M, Figueiredo P, Vourvopoulos A, et al. Two is better ? Combining EEG and fMRI for BCI and neurofeedback: a systematic review[J].2023. [8] Askovic M, Soh N, Elhindi J, et al. Neurofeedback for post-traumatic stress disorder: systematic review and meta-analysis of clinical and neurophysiological outcomes[J]. Eur J Psychotraumato, 2023, 14. [9] 鲁萍萍, 王 亮. 创伤后应激障碍的经颅磁刺激研究进展[J]. 生物化学与生物物理进展, 2020, 47(4):319-334. [10] Edinoff A N, Hegefeld T L, Petersen M, et al. Transcranial magnetic stimulation for post-traumatic stress disorder[J]. Front Psychiatry, 2022, 13:701348. [11] Khitha V, Tayade S. Application of deep brain stimulation in refractory post-traumatic stress disorder[J]. Cureus, 2023, 15(1):e33780. [12] Beszłej J A, Wieczorek T, Kobyłko A, et al. Deep brain stimulation: new possibilities for the treatment of mental disorders[J]. Psychiatria Polska, 2019, 53(4):789-806. [13] Jeffreys M. Clinician's guide to medications for PTSD. 2016: 41-64. [14] Abdallah C G, Averill L A, Akiki T J, et al. The neurobiology and pharmacotherapy of posttraumatic stress disorder[J]. Annu Rev Pharmacol Toxicol, 2019, 59:171-189. [15] 赵泽丰, 年 梦, 吕 红, 等. 药物通过调节神经递质治疗创伤后应激障碍的研究进展[J]. 西北药学杂志, 2023, 38(3):211-217. [16] Cenkner D P, Asnaani A, DiChiara C, et al. Neurocognitive predictors of treatment outcomes in cognitive processing therapy for post-traumatic stress disorder: study protocol[J]. Front Psychol, 2021, 12:625669. [17] Kida S. Reconsolidation/destabilization, extinction and forgetting of fear memory as therapeutic targets for PTSD[J]. Psychopharmacology (Berl), 2019, 236(1):49-57. [18] Miller P W, McGowan I W, Bergmann U, et al. Stochastic resonance as a proposed neurobiological model for eye movement desensitization and reprocessing (EMDR) therapy[J]. Med Hypotheses, 2018, 121:106-111. [19] Hölzel B K, Carmody J, Vangel M, et al. Mindfulness practice leads to increases in regional brain gray matter density[J]. Psychiatry Res, 2011, 191(1):36-43. [20] 袁 媛, 孙 溦. 正念减压疗法对创伤后应激障碍干预效果的Meta分析[J]. 联勤军事医学, 2023, 37(8):720-725. [21] 蒋雅琼, 刘 颖, 陈露露, 等. 接纳与承诺疗法对重症监护病房转出患者创伤后应激障碍及创伤后成长的影响[J]. 实用医院临床杂志, 2024, 21(1):163-167.
PDF(931 KB)
